Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin K2 for Glucocorticoid-Induced Bone Loss in Pediatric Nephrotic Syndrome
NCT07206537Recruiting
- Sponsor
- Ain Shams University
- Start
- Apr 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of menaquinone in glucocorticoid-induced osteoporosis (GIOP) (2 arms), sponsored by Ain Shams University. Primary endpoint: Prevention of Glucocorticoid-Induced Bone Loss at 6 months. Started Apr 2025; status: recruiting.
02
Drugs
menaquinone
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on NCT07206537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07206537.